Workflow
塔吉特(TGT)
icon
搜索文档
LyondellBasell Secures Capacity to Meet Renewable Electricity Target
ZACKS· 2024-09-25 20:15
LyondellBasell Industries N.V. (LYB) stated that it has signed a power purchase agreement (PPA) with Eneco N.V.  This PPA brings LYB's total secured renewable power capacity to 100% of its renewable electricity procurement goal.LYB's electricity consumption constitutes approximately 15% of its 2020 baseline scope 1 and 2 greenhouse gas emissions. The company's objective of obtaining at least 50% of its electricity from renewable sources by 2030 is based on 2020 procurement levels.Under the 15-year PPA, LYB ...
Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension
GlobeNewswire News Room· 2024-09-25 20:00
– On track to announce topline data in Q1 2025 – – Virtual KOL event scheduled on October 30th to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program for lorundrostat in hypertension – RADNOR, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other prevalent cardiovascular diseases driven by dysr ...
Target Hospitality Provides Business Update
Prnewswire· 2024-09-25 18:45
- Target Hospitality Board Disbands Special Committee -- Target Hospitality to Reinvigorate Focus on Allocating Capital to High Return Initiatives, Including In-Organic Growth -- Reaffirms 2024 Outlook Given Strength of Year-to-Date Operating Results -THE WOODLANDS, Texas, Sept. 25, 2024 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality," "Target" or the "Company") (Nasdaq: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality s ...
Levi's Teases Beyonce Collaboration, Delays Revenue Target
Investopedia· 2024-09-25 03:05
Key TakeawaysLevi Strauss posted a stylized image resembling Beyonce's "Cowboy Carter" album cover on Instagram that may hint at a collaboration with the superstar.Levi's CEO Michelle Gass reportedly pushed back the company's goal of reaching $9 billion to $10 billion in annual revenue by 2027.The company earlier this year reported $6.2 billion in revenue for its fiscal 2023. Levi Strauss & Co. (LEVI) hinted that a collaboration with superstar Beyonce may be on the horizon in an Instagram post on Monday. Th ...
Here's How Target is Gearing to Take on Rivals This Holiday Season
ZACKS· 2024-09-25 01:40
文章核心观点 - 公司为假日季做好充分准备,通过提供优惠、扩充产品阵容、增加员工等措施,有望在竞争激烈的零售市场中占据一定份额,实现良好销售业绩 [1][6][7] 假日活动安排 - 公司于10月6 - 12日开启Target Circle Week活动,提供秋季热门商品和日常必需品的独家折扣,加入免费Target Circle会员即可享受 [2] - 活动期间Deal of the Day项目回归,提供一日促销,活动将延续至11月,且在节前几周还有更多惊喜和折扣 [2] 产品供应情况 - 公司今年假日产品阵容增加,新增商品数量比去年多50%,包括超1000种热门品牌新玩具,还有节日服装、家居装饰和独家美妆礼品 [3] - 公司注重产品价值,超半数玩具价格低于20美元,数千种小礼品售价低于5美元,还有独家合作商品 [3] 人员招聘计划 - 为满足假日需求,公司计划在门店和供应链设施招聘约10万名季节性员工,以保障订单处理和服务效率 [4] 购物服务选项 - 消费者可选择Drive Up、Order Pickup、Shipt当日达等灵活配送方式,订单满35美元还可享受免费两日送达服务 [4] - Target Circle会员使用Target Circle卡购物可额外享受5%折扣 [4] 行业销售预测 - 德勤预计,11月至1月期间假日零售销售额同比增长2.3% - 3.3%,总额达1.58 - 1.59万亿美元,电商销售额预计增长7% - 9%,达2890 - 2940亿美元 [6] 公司股价表现 - 过去三个月,公司股价上涨5.8%,高于行业3.4%的涨幅 [7]
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis
Newsfile· 2024-09-24 19:27
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute MyocarditisSeptember 24, 2024 7:27 AM EDT | Source: Cardiol Therapeutics Inc.Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of ...
Gold (XAU) Daily Forecast: Upward Channel Supports Rally – Next Target $2,650?
FX Empire· 2024-09-24 15:23
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
GlobeNewswire News Room· 2024-09-23 20:00
- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it has achieved their target patient enrollment in the VIRAGE Phase 2b cl ...
MYT Netherlands: Medium-Term Growth Target Is Plausible
Seeking Alpha· 2024-09-23 19:46
My recommendation for MYT Netherlands Parent (NYSE: MYTE ) is a buy rating. I am positive that the strategy MYTE has employed will help it drive growth to a low 20% over the medium term. Notably, the flywheel effect that MYTEI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-t ...
3 Reasons Why Target Will Smash Sales This Holiday Season
Seeking Alpha· 2024-09-23 12:04
I recently joined The REIT Forum and if you are looking for more investment ideas like this one, get them exclusively at The REIT Forum with access to our subscriber only portfolios.With comparable sales turning positive in Q2 FY24 after four consecutive quarters of decline and operating margins steadily rising, Target (NYSE: TGT ) is showing improving trends in its fundamentals with strength inAmrita runs a boutique family office fund in beautiful Vancouver, where she leads the investment strategy for the ...